1.   Biotechnology shares were higher.

2.   Biotechnology shares also extended their recent losses.

3.   It was a very good day for biotechnology shares, which continued their torrid rise.

4.   Like most of the stock market, biotechnology shares have fallen recently.

5.   Massachusetts stocks dropped, ending a six-day gain, as investors say the year-long rally in biotechnology shares may cool off.

6.   Naqvi sold many of those stocks and replaced them with Amgen and other biotechnology shares.

7.   Other biotechnology shares rose.

8.   She and other analysts say investors who profited from Internet investments are moving money into biotechnology shares to catch the next big boom.

9.   U.K. biotechnology shares surged in London for the second straight day as investors waded into the risky sector to buy into companies with promising drugs getting closer to market.

10.   Gains in biotechnology shares outweighed declines in technology stocks.